Background: Protein restriction causes metabolic programming to maintain glucose homeostasis in rodents. They develop increased insulin sensitivity in peripheral tissues and reduced insulin secretion by pancreatic β cells. Estradiol (E2) is a steroid hormone involved in the control of energy balance and glucose homeostasis. Here, we assessed the role of estrogen receptors (ERs) on glucose homeostasis in malnourished mice and the effect of E2 on insulin signaling.
Introduction
Protein restriction in utero or in the perinatal period alters glucose homeostasis, programming the organisms to maintain adequate glucose levels to guarantee the correct energy distribution [1, 2] . The main adjustments are represented by alterations in pancreatic β-cell physiology and insulin activity in peripheral tissues. Glucose-stimulated insulin secretion (GSIS) is reduced as a consequence of a modified mechanism of secretion [3] [4] [5] , associated with a reduction in insulin content and β-cell mass. In addition, insulin sensitivity is enhanced in muscle and liver, as judged by the increase in insulin receptor (IR), insulin receptor substrate-1 (IRS-1) and AKT phosphorylation [6] [7] [8] [9] . The combination of these major functional adaptations allows an adequate glucose response in hypoinsulinemic subjects.
The hormone 17-β-estradiol (E2) and the estrogen receptor (ER) play an important role in controlling glucose [10] and energy [11] homeostasis. Knockout (KO) mice for ER alpha (ERα) presented impaired glucose homeostasis (glucose intolerance and insulin resistance) and developed obesity [12] [13] [14] . In pancreatic β cells, ERα increases the insulin content by activating the nuclear factor NeuroD1 [15, 16] . Furthermore, E2, through ER beta (ERβ), increases insulin secretion, closing the ATPsensitive potassium channel and increasing calcium influx [17] .
In peripheral tissues, both ERα and ERβ isoforms are involved in the effect of E2 on the insulin signaling pathway. In the liver, ERαKO mice show increased gene expression of lipogenic transcription factors, such as sterol regulatory element binding protein 1c (SREBP-1c) and decreased gene expression of lipid transport [18, 19] . ERαKO mice exhibit impaired glucose tolerance and hepatic insulin resistance, whereas ERβ-deficient mice show normal glucose tolerance, suggesting that ERα, but not ERβ, plays an important role in the regulation of hepatic glucose homeostasis [18] . The absence of ERα in the different ERα-PI3K Interaction and Insulin Sensitivity J Endocrinol Metab. 2019;9(5):133-146 sexes causes hyperplasia and hypertrophy in white adipose tissue (WAT) [12] . In females, estrogen deficiency increases the amount of WAT depots that was reduced with estrogen replacement [20] . Both ER isoforms are present in muscle tissue; however, ERα is expressed at a much higher rate than ERβ. ERαKO mice show marked insulin resistance in muscle [21, 22] , while homozygous deletion of ERβ failed to produce insulin resistance [23, 24] . The mechanisms by which E2 regulates metabolism in muscle are still poorly understood. E2 stimulates the phosphorylation of Akt, AMP-activated protein kinase (AMPK) and the Akt substrate TBC1D1/4 in soleus muscle from normal rats [25] . In addition, ovariectomized female rats treated with E2, yielding levels similar to those observed in pregnancy, show decreased insulin sensitivity as well as reduced GLUT4 expression and translocation in skeletal muscle [26] . When E2-deficient ARKO male mice are treated with the selective ERβ agonist (DPN), a reduction in GLUT4 expression in muscle was observed [27] . Glucose uptake in muscle was reduced when ERα was absent [18] . Furthermore, in the physiological range, E2 is beneficial for insulin sensitivity, whereas hypo-or hyperestrogenism is related to insulin resistance [28] .
Testosterone is the other steroid hormone that acts through the androgen receptor (AR). The role of AR in glucose homeostasis is less well understood than that of ERs. Male mice lacking AR in pancreatic β cells exhibit decreased GSIS, leading to glucose intolerance. The AR agonist dihydrotestosterone (DHT) increases GSIS in both human and mouse islets. This insulinotropic effect of DHT depends on activation of the glucagon-like peptide-1 receptor and amplifies its incretin effect [29] . Testosterone deficiency promotes insulin resistance in peripheral tissues, at least partially, via an AR-dependent mechanism involving a decrease in PGC1α as well as increased visceral WAT and liver steatosis [11] . Hyperandrogenism is a risk factor for metabolic syndrome in women, independent of obesity and insulin resistance [30] . Furthermore, the effect of insulin on whole-body glucose uptake was decreased when healthy women were treated with testosterone [31] .
Despite the above information, how estradiol and ERs affect glucose homeostasis in protein malnutrition is unknown. Thus, we investigated whether the effects of ERs on metabolic parameters are altered in protein-malnourished mice. Furthermore, we explored how acute E2 exposure affects insulin sensitivity in malnourished mice. 
Materials and Methods

Materials
Experimental animals
All experimental protocols were approved by the ethics committee at UNICAMP (protocol number: 3638-1 and 4604-1/2017) and conformed to the guidelines for ethical conduct in the care and use of animals established by the Brazilian Society of Laboratory Animal Science (SBCAL/COBEA). Male Swiss mice were purchased from the Multidisciplinary Centre for Biological Research at UNICAMP (Campinas, SP, Brazil). Weaned mice (21 days old) were randomly separated into two different groups: one group was fed a chow diet containing a normal protein level (control, 14%), and the other group was fed a low-protein diet (LP, 6%) for 8 weeks (diet compositions are described [32] ; Pragsolucoes Biociencias, Jau -SP, Brazil). During the protocol, mice were maintained at 22 ± 1 °C on a 12-h light/dark cycle with free access to water and food.
Plasma analysis
After euthanasia, global blood was collected by decapitation. Plasma samples were obtained by centrifugation for 15 min at 1,200 rpm at 4 °C and stored at -80 °C until use. The insulin, estradiol and testosterone levels were analyzed by ELISA kits (EZRMI-13K Rat/Mouse Insulin ELISA, Millipore; Mouse/Rat estradiol ELISA, cat. no. ES180S-100, Calbiotech; Free testosterone ELISA, cat. no. FT178S, Calbiotech, respectively). Albumin and protein levels were measured by colorimetric assay (Bioclin (cat. no. K040, Belo Horizonte MG, Brazil) and invitro Diagnostica (cat. no. 013, Itabira MG, Brazil), respectively).
Real-time quantitative polymerase chain reaction (qPCR)
qPCR assays were performed using a 7500 real-time PCR system (Applied Biosystems, Foster City, CA). Approximately 100 mg of tissue or 300 isolated islets were used for RNA extraction. RNA extraction was performed with TRIzol Reagent (cat. no. 15596026, Ambion by Life Technologies) or an RNeasy Mini Kit (cat. no. 74104, Qiagen, USA), and 1 µg of RNA was used for the reverse transcription reaction (High Capacity cDNA Reverse Transcription; cat. no. 4368814, Applied Biosystems). Expression levels were normalized to the expression of ribosomal protein large P0 (Rplp0), also known as 36B4, and hypoxanthine phosphoribosyltransferase 1 (Hrpt). The results were expressed as the relative expression with respect to control levels (2-ΔΔCT) [33] . Primer sequences are listed in the Supplementary Table 1 (www.jofem.org).
Western blotting
For Western blotting, 20 -50 µg of total protein was used to 
Euglycemic-hyperinsulinemic clamp
A euglycemic-hyperinsulinemic clamp was carried out with a prime continuous insulin infusion (30 mU/kg/min). Blood glucose was measured at 5-min intervals, and glucose (5% wt./ vol.) was infused at a variable rate to maintain blood glucose at fasting levels (90 -120 mg/dL) for 30 min. After this period, animals were stimulated with prime continuous E2 infusion (10 µg/kg body weight (bw)) to evaluate the effect of E2 on insulin sensitivity. Fasting blood glucose levels were restored by glucose infusion, and glycemia was measured at 5-min intervals. The period used to study the effect of E2 was after glycemia was stable for 30 min.
Islet cell isolation
Islets of Langerhans were isolated by collagenase (Sigma Chemical, St. Louis, MO, USA) digestion (modified from [34] ). The solution used for the isolation of the islets contained (in mmol/L): 115 NaCl, 10 NaHCO 3 , 5 KCl, 1.1 MgCl 2 , 1.2 NaH 2 PO 4 , 2.5 CaCl 2 , 25 HEPES and 5 D-glucose, pH 7.4, as well as 0.25% BSA.
[18F]-FDG positron emission tomography/computed tomography (PET/CT) scan
Metabolic (PET) and CT images were acquired and processed using an ALBIRA System, a small animal PET/SPECT/CT in vivo imaging system (Bruker ® Corporation, Massachusetts, USA), and they were analyzed using PMOD software (PMOD Technologies LLC Zurich, Swiss). Mice were fasted for 6 h and anesthetized with 2% isoflurane. Approximately 300 µC of [18F]FDG was injected into the venous sinus with or without 10 µg/kg bw of E2 in a final volume of 100 µL. After 40 min of [18F]FDG distribution (uptake) at 23 -24 °C, PET images were acquired. PET scans lasted a total duration of 40 min. The CT scan was performed immediately after the PET scan without changing the position of the mice, always in the cranium-caudal direction from head to proximal thighs. The CT was performed as a low-dose acquisition with 35 kVp, 400 µA and 600 projections with a field of view of 71.3 mm/bed. PET scans were reconstructed using PMOD software, and images were calibrated in Bq per mL by scanning a cylindrical phantom. The volume of interest (VOI) was drawn manually on CT volume and copied to fused PET images. PET images of uptake (Bq/mL) were measured, and the usual standardized uptake values (SUVs) for body mass were calculated.
Glucose (FDG) uptake by gamma counter
Male mice were fasted for 6 h, and they were anesthetized with a mixture of ketamine and xylazine. Approximately 30 µC of [18F]FDG was injected into the venous sinus with or without 10 µg/kg bw of E2 in a final volume of 100 µL. After 40 min of [18F]FDG biodistribution (uptake) at 23 -24 °C, the animals were euthanized, and the circulating blood was extracted to avoid contaminating tissues with the radiolabel [18F]FDG. Finally, the different organs were removed. The activity of the radiolabel [18F]FDG in each tissue was acquired by the Wizard 2 2-Detector Gamma Counter (PerkinElmer). The usual SUVs for body mass were calculated using the total uptake (Bq/g)/ the total activity administered × the mouse mass.
Insulin signaling
Mice in the fed state were stimulated with PBS (negative control), 5 UI insulin (positive control) and 5 UI insulin + 10 µg/ kg E2. After 5 min, the animals were sacrificed, and the tissues were removed and ultra-frozen in liquid nitrogen. Samples were stocked at -80 °C until they were used for Western blotting analysis.
Co-immunoprecipitation assay
Frozen muscle tissue was homogenized in NP-40 lysis buffer (50 mM Tris HCL, pH 7.4; 1% NP 40; 50 mM NaCL; 10% glycerol; 1 mM EDTA and cOmplete™ Protease Inhibitor Cocktail (cat. no. 11697498001; Roche)). The samples were maintained in constant agitation for 2 h at 4 °C. The lysate samples were pre-cleared. For this step, we used protein Asepharose beads (cat. no. 17-0469; GE Healthcare), and the lysate samples were rotated for 1 h at 4 °C. After this time, samples were centrifuged, and the supernatant was collected.
The protein concentration of the pre-cleared lysate was quantified by the Pierce method (cat. no. 22660; Thermo Fisher). An aliquot of 10% input of each sample as whole-cell lysate was saved. Afterwards, they were run as pre-cleared input samples as a control loading for the blotting gel.
We used 0.5 mg of protein in the immunoprecipitation assay. For each reaction, we added 2 µg of ERα antibody (sc-542; Santa Cruz Biotechnology). The conjugated protein-antibody was precipitated with protein A/G plus agarose (sc-2003; Santa Cruz Biotechnology). Reducing sample buffer was added, and ERα-PI3K Interaction and Insulin Sensitivity J Endocrinol Metab. 2019;9(5):133-146 the samples were boiled. They were run on a Western blotting gel or stored at -80 °C. The immunoblotted protein was the p100α subunit from PI3Kinase (#4249; Cell Signaling Technology).
Statistical analysis
GraphPad Prisma 6 software for Windows (GraphPad Software, La Jolla, CA, USA) was used for all statistical analyses. To assess differences between treatment groups for each exposure paradigm, we used one-way analysis of variance (ANO-VA) and Student's t-test to compare two groups. The results were considered significant at P < 0.05. Data are shown as the mean ± standard error of the mean (SEM).
Results
ER and AR in malnourished mice
Malnourished male mice exhibited lower body weight ( Fig.  1a , b) and decreased plasma insulin ( Fig. 1c ), protein ( Fig. 1d ) and albumin levels ( Fig. 1e ) in the fed state compared with controls. According to the literature, these data confirmed that this animal model is a good representation of protein restriction. In addition, no information was available regarding steroid hormone plasma levels in malnourishment. We found a marked increase (1.7 times) in E2 in LP compared with control ( Table 1 ). In contrast, free testosterone levels were decreased by 3.3-fold in the LP group. Different expression profiles of ER genes were observed, depending on the tissue and isoform studied (Fig. 2 ). In the liver, LP mice showed decreased expression of ERα compared with controls ( Fig. 2a ) and increased expression of the β isoform ( Fig. 2b ). By contrast, in gastrocnemius muscle, both isoforms, α and β, were increased in LP compared with control ( Fig. 2c, d) . In white adipose tissue, ERα and β showed a decrease in their expression levels ( Fig. 2e, f) . In pancreatic islets, we observed increased expression of ERα, whereas ERβ was unaltered (Fig. 2g, h) .
The fact that LP mice showed increased ERβ expression in the liver, an isoform usually low in this tissue, led us to think that the general expression profiles of the receptors could be altered throughout the whole body in these mice. Thus, we performed a comparative study using hypothalamus and lung tissues for positive control of ERα and ERβ expression, respectively. The data did not show any change in the whole expression profile in either ER isoform ( Supplementary Fig. 1 , www.jofem.org).
The differences found in gene expression did not reflect the protein profile (Fig. 3 ). In the liver (Fig. 3a, b) , no differences were observed in ERα or ERβ levels; however, we did observe a significant increase in the small isoform, ERα36. In muscle (Fig. 3c, d) , adipose tissue (Fig. 3e, f) , and pancreatic islets (Fig. 3g, h) , the levels of α and β receptors were similar in mice of both groups.
No changes in AR gene expression were observed in liver, adipose tissue or pancreatic islets of LP compared with control mice (data not shown). Nevertheless, the expression of AR in muscle was reduced in LP ( Fig. 4a ), even though the AR protein content was not different between groups (Fig. 4b ).
Effect of E2 on insulin sensitivity
Insulin sensitivity was addressed using a euglycemic-hyperinsulinemic clamp technique. Mice were exposed to a prime continuous influx of insulin and a variable rate of glucose to maintain blood glucose at fasting levels. After 30 min of stable glycemia, we stimulated the mice with a prime continuous influx of E2 ( Supplementary Fig. 2 , www.jofem.org). The LP group showed increased insulin sensitivity in peripheral tissues reflected by an increase in the glucose infusion rate (GIR) and glucose uptake, as described in the literature. When the mice were stimulated in a concomitant way with insulin and E2, LP mice showed an increase in insulin sensitivity after E2 exposure. This increase was reflected by an augmented GIR compared with that of the LP group stimulated only with insulin and compared with the control group (in both vehicle and E2 conditions) ( Fig. 5a, b ). Overall, our results show that E2 promoted an exacerbated increase in insulin sensitivity in protein-restricted mice. This effect was rapid and was observed approximately 5 min after E2 administration ( Supplementary  Fig. 2 , www.jofem.org). We explored whether ER and which isoform/s were involved in this phenomenon. For this assay, we treated LP mice with a variety of ER antagonists. First, we treated LP mice with a general antagonist of ER, ICI 182,780 (ICI), for 4 days (500 µg/kg bw/day) [35, 36] . After ICI administration, the effect of E2 in LP mice was absent; no changes were found in GIR or in glucose uptake (Fig. 5c, d) . Second, we determined which receptor isoform was involved. For this part, mice were treated with a specific ERα antagonist (MPP) or an ERβ antagonist (PHTPP). MPP blunted the effect of E2, whereas PHT-PP-treated mice showed an increase in insulin sensitivity when stimulated with E2, represented by an augmented GIR and glucose uptake, similar to that observed in the control experiment (LP mice treated with the vehicle that received insulin and insulin + E2). In contrast, we observed a tendency to decrease insulin sensitivity in the PHTPP-treated mice stimulated only with insulin and a significant decrease in glucose uptake (Fig.  5c, d) . We conclude that the improvement in insulin sensitivity elicited by E2 in protein-restricted mice was ERα-mediated.
To rule out whether this effect is sex-dependent, we performed the euglycemic-hyperinsulinemic clamp in female LP mice (phenotype described in Supplementary Fig. 3 , www. jofem.org). Female mice also showed an increase in insulin sensitivity when they were stimulated with insulin and E2. Thus, the effect was similar in both sexes (Fig. 6 ).
Effects of E2 on glucose uptake in peripheral tissues
In male protein-restricted mice, E2 effects on insulin sensitivity were reflected by higher glucose uptake. We assessed which peripheral tissues responded to E2 stimulation using a In Figure 7a and b, representative pictures showed differential accumulation of [18F]FDG in the tissues (3D reconstruction of the scanning is shown in the Supplementary Videos, www. jofem.org). A higher [18F]FDG concentration was observed in LP male mice exposed to E2 (Fig. 7b ) compared with the control group (Fig. 7a ). When we studied glucose uptake, representing an SUV, in specific structures, we observed a significant increase in the SUV in LP mice stimulated with E2 in the muscle of the hind legs ( Fig. 7c) but not in the liver (Fig. 7d ). However, due to the characteristics of the image acquired, it was not possible to address the study question using this technique to analyze the perigonadal adipose tissue. Therefore, we measured the radiolabeling in different tissues using a gamma counter ( Supplementary Fig. 4 , www.jofem.org). No differences were observed in the SUV between LP mice, stimulated or not stimulated with E2, in both perigonadal adipose tissue and liver ( Supplementary Fig. 4A and B , www.jofem.org). However, the SUV (P = 0.053) was increased in the gastrocnemius muscles in mice stimulated with E2 compared with controls ( Supplementary Fig. 4C , www.jofem.org).
In muscles from male malnourished mice, the effect of E2 on the insulin pathway is reflected by increased AKT phosphorylation (Fig. 8a) . No differences in AKT phosphorylation were found in the liver or adipose tissue under insulin or E2 conditions (data not shown).
Studies in the breast cancer cell line MCF7 demonstrated that E2 stimulates cell growth through the upregulation of phosphatidylinositol 3-kinase (PI3K)/AKT signaling via ERα [37] . Based on this evidence, we investigated whether this process occurs in LP male mice. When we immunoprecipitated ERα from gastrocnemius samples and immunoblotted the PI3K (the p110 subunit), we observed a higher intensity band in the muscles of malnourished male mice stimulated with E2 and insulin in a concomitant way (Fig. 8b) . These data indicate a higher interaction between ERα and PI3K in the presence of E2, increasing the activation of the PI3K/AKT pathway and inducing a consequent increase in p-AKT.
Is insulin sensitivity increased via ERα co-regulators?
Post-transcriptional regulation of ERs plays a key role in controlling their activity. For example, in human breast cancer cells, overexpression of SCR-3 resulted in a decreased response of ERs to tamoxifen [38] [39] [40] . When we studied this co-activator in the muscles of the different groups 5 min after insulin or insulin + E2 stimulation, we did not observe differences in the protein content in any group ( Supplementary Fig.  5A , www.jofem.org).
Temporary methylation in the R260 of ERα by PRMT1 induces the formation of a cytoplasmic complex, formed by ERα, PI3K, tyrosine kinase SCR and FAX, and it increases AKT activity [41] . Our data did not show alterations in the PRMT1 content in the muscle ( Supplementary Fig. 5B , www.jofem. org). PELP1 is another co-activator of ER that acts as a scaffold, regulating the interaction between ER and SRC, activating SRC and the family of ERK kinases and subsequently activating PI3K via estrogen [42, 43] . We did not find expression of this protein in the muscle of Swiss mice (data not shown).
Discussion
In the present study, we demonstrated that E2 has an important acute effect on insulin sensitivity in protein-restricted mice. In particular, E2 improves insulin sensitivity in an ERα-dependent manner. We also found that ERα activates the PI3K signaling pathway with a subsequent increase in Akt phosphorylation in the gastrocnemius muscle of LP mice. This increased Akt activity leads to an augmented glucose uptake, which contributes to the improvement of insulin action. No changes were found at the ER protein levels in the different tissues examined, suggesting that the expression profile does not influence the E2 effect.
In addition, we found an upregulation of circulating E2 in LP male mice, accompanied by a decrease in circulating free testosterone levels (Table 1 ). This phenomenon is comparable to what occurs in ageing men, where an increase in E2 and a decrease in T levels were observed, in contrast to that observed in healthy young subjects. It is known that men with lower T levels are at higher risk of developing metabolic syndrome [44] . A higher ratio of T/E2 may protect against it, since higher T levels are linked to better insulin sensitivity [45] . In addition, it is known that AR is involved in adiponectin physiology. Adiponectin plasma levels are high in hypogonadal men and are reduced by T therapy [46] . T infusion also decreases adiponectin in mice [47] , an effect that is at least partially mediated via AR, since adiponectin is increased in AR-deficient mice [48] . In LP mice, adiponectin is increased [32] , which could explain the higher basal insulin sensitivity in this model.
The increased E2 levels reflect increased aromatase activity in LP mice, and the aromatization of T into E2 is critical for energy homeostasis in males [11] . Orchiectomized male rodent, treated either with T or E2, remain lean, while those treated with the pure androgen DHT (that is not aromatized to E2) develop obesity [49] .
The ERs were involved in glucose homeostasis [12] [13] [14] 50] , and they may be implicated in higher insulin sensitivity in malnourished rodents. Figure 2 shows that ER gene expression is modulated by diet; however, these changes in gene expression did not reflect alterations in protein content (Fig. 3) . Thus, the increased insulin sensitivity in these mice cannot be explained by modification of the ER protein content.
E2 is a steroid hormone that favors insulin sensitivity. In ovariectomized rodents, a reduction in circulating E2 provokes insulin resistance and impairment of muscle glucose disposal [51] . In menopausal women, there is a decline in insulin sensitivity concomitant with an increase in fat mass and higher levels of circulating inflammatory markers [52] . In LP mice, we observed a rapid response to E2, within approximately 5 min after its administration. LP mice showed a profound decrease in glycemic levels ( Supplementary Fig. 2 , www.jofem. org) and consequently, an increase in the GIR to restore the blood glucose to fasting levels (Fig. 4a) . The E2-mediated improvement in insulin sensitivity was linked to an enhancement of glucose uptake in LP mice (Fig. 4b) . This effect is not sex-dependent since female LP mice showed similar effects on GIR and glucose uptake after E2 stimulation. This effect on insulin sensitivity is a consequence of protein restriction, producing metabolic re-programming in mice, independent of sex. Conflicting results have been found in clinical studies in which insulin action was evaluated in euglycemic-hyperinsulinemic clamp assays in menopausal women under menopausal hormone therapy (MHT) [53] . Pereira et al [54] proposed that the results could be conditioned by the temporal window after the last menses. They observed that E2 increased insulin action in early postmenopausal women but decreased it in late postmenopausal women. This finding suggests that the ben-eficial effect of E2 on insulin sensitivity depends on the time period since the onset of menopause. In LP male mice, where we can isolate the high and cycling E2 levels, insulin action is increased in the presence of E2, and its effect is produced by a There is some controversy about the role of ER and the α and β isoforms in muscle. The results in wild-type vs. KO animals or using a nonsteroidal selective ER modulator, such as tamoxifen, suggest that ERβ is the main isoform in skeletal muscle, acting as a repressor of GLUT4 expression. However, ERα is involved in GLUT4 translocation, and its absence in KO animals decreases GLUT4 expression [27, 55] . Our data showed that ERα is responsible for the increased insulin sensitivity ( Fig. 5 ). When LP male mice were treated with a general ER antagonist, the effect of E2 was abolished. When they were treated with an ERα-specific antagonist, MPP, the effect was also prevented. In contrast, E2 increased insulin sensitivity when male mice were treated with PHTTP, an ERβ-specific antagonist. This pharmacological approach allows us to conclude that the effect of E2 on insulin sensitivity occurs in an ERα-mediated manner.
To skip the fact that muscle is the main tissue that regulates glucose uptake under the influence of insulin, we studied the effect of E2 on glucose uptake using the PET/CT scan technique. In the absence of exogenous insulin, E2 increased FDG uptake in muscle ( Fig. 7 and Supplementary Fig. 4 , www. jofem.org), and this result confirms that there is a direct effect of E2 in glucose homeostasis in LP male mice, independent of the hyperinsulinemic condition of the clamp, where the glucose administered is driven preferentially into skeletal muscle and only the insulin-dependent fraction of glucose uptake is explored [56] [57] [58] [59] . This increase in glucose uptake was produced by an augmentation of AKT phosphorylation, which increased the level of GLUT4 at the cellular plasma membrane. This increased phosphorylation was a consequence of the direct interaction of ERα with PI3K.
Studies in human cell lines [38] [39] [40] [41] [42] [43] and in silico show that ERα activity could be modulated by different co-regulators, such as SCR3, PRMT1 or PELP1. Our results showed that PELP1 was not expressed in male mouse muscle (data not shown) and that E2 did not influence the activity of the other co-regulators. Both SCR3 and PRMT1 did not show any change compared with the control group, suggesting that neither E2 nor LP diet influenced their quantity ( Supplementary Fig. 5 , www.jofem.org).
Conclusion
In summary, our results show an acute effect of estradiol on insulin signaling in skeletal muscle in protein-restricted mice. This potentiation in the insulin pathway is mediated by the ERα. The ER directly interacts with PI3K, which increases the phosphorylation of AKT and consequently, glucose uptake in muscle. However, the results suggest that ERs are not involved in the adaptation to the metabolic programming produced by LP in mice. These data could offer a novel approach to develop a new combination of compounds with E2 to increase insulin sensitivity, specifically in muscle.
